Menu
Back to Journals » Drug Design, Development and Therapy » Volume 13
Review
Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,501 | Dovepress* | 9,237+ | 1,664 | 10,901 | |
| PubMed Central* | 4,264 | 1,143 | 5,407 | ||
| Totals | 13,501 | 2,807 | 16,308 | ||
| *Since 23 July 2019 | |||||
View citations on PubMed Central and Google Scholar